Brokerages Set DocGo Inc. (NASDAQ:DCGO) Target Price at $6.10

Shares of DocGo Inc. (NASDAQ:DCGO) have been assigned an average recommendation of “Buy” from the five ratings firms that are currently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $6.10.

A number of brokerages recently commented on DCGO. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research report on Tuesday, August 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $7.00 target price on shares of DocGo in a report on Thursday, August 8th.

DocGo Stock Down 1.1 %

NASDAQ DCGO opened at $3.53 on Monday. DocGo has a twelve month low of $2.75 and a twelve month high of $6.90. The company has a market cap of $358.53 million, a price-to-earnings ratio of 17.65, a price-to-earnings-growth ratio of 3.02 and a beta of 0.92. The business’s fifty day moving average is $3.47 and its 200 day moving average is $3.41.

DocGo (NASDAQ:DCGO) last announced its earnings results on Wednesday, August 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The company had revenue of $164.95 million for the quarter, compared to analyst estimates of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. On average, research analysts anticipate that DocGo will post 0.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DocGo

Several institutional investors have recently bought and sold shares of DCGO. Point72 Asset Management L.P. increased its holdings in shares of DocGo by 1,655.7% in the second quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company’s stock worth $361,000 after purchasing an additional 110,189 shares during the period. The Manufacturers Life Insurance Company grew its stake in shares of DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after buying an additional 9,696 shares during the last quarter. Marathon Capital Management grew its stake in shares of DocGo by 2.3% during the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock valued at $856,000 after buying an additional 6,285 shares during the last quarter. Deerfield Management Company L.P. Series C grew its stake in shares of DocGo by 41.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock valued at $22,236,000 after buying an additional 2,091,569 shares during the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of DocGo by 58.5% during the second quarter. AQR Capital Management LLC now owns 344,963 shares of the company’s stock worth $1,066,000 after purchasing an additional 127,320 shares during the period. Hedge funds and other institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.